Nektar Therapeutics (NASDAQ:NKTR)

Tuesday’s Biggest Winners and Losers in the S&P 500

January 8, 2019: The S&P 500 closed up 1.0% at 2,574.42. The DJIA closed up 1.1% at 23,787.58. Separately, the Nasdaq closed up 1.1% at 6,897.00. Tuesday was a positive ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE, Marvell, Monster Beverages, Nabors, Procter & Gamble and More

The futures traded slightly higher Thursday morning as the markets digested yesterday's upside move. Positive talk on trade and some more benign inflation data were seen as the key reasons ...
Read Full Story »

Monday’s Biggest Winners and Losers in the S&P 500

November 12, 2018: The S&P 500 closed down 2.0% at 2,726.32. The DJIA closed down 2.3% at 25,388.54. Separately, the Nasdaq closed down 2.8% at 7,200.87. Monday was a down ...
Read Full Story »

Tuesday’s Biggest Winners and Losers in the S&P 500

November 6, 2018: The S&P 500 closed up 0.6% at 2,755.46. The DJIA closed up 0.7% at 25,638.47. Separately, the Nasdaq closed up 0.6% at 7,375.96. Tuesday was a positive ...
Read Full Story »

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar Therapeutics (NASDAQ: NKTR) shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer Inc. (NYSE: PFE) to evaluate several combination regimens in multiple cancer ...
Read Full Story »

Monday’s Biggest Winners and Losers in the S&P 500

October 1, 2018: The S&P 500 closed up 0.4% at 2,924.81. The DJIA closed up 0.8% at 26,662.37. Separately, the Nasdaq closed flat at 8,037.30. Monday was a mixed day ...
Read Full Story »

Why Nektar Therapeutics Shares Are Tumbling

Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results were presented ...
Read Full Story »

Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates

Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and ...
Read Full Story »

Jefferies Has 4 Red-Hot Growth Stocks to Buy Despite Volatility

One thing's for sure: if the last two weeks haven’t left some investors a little shell-shocked, then they are lying or they sold out in front of all the selling. ...
Read Full Story »

50 Mid-Cap and Larger Stocks More Than Doubled in 2017

With 2017 nearing an end, it is important to consider just what has happened. Tax reform looks very likely now, and gross domestic product is higher in the United States ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

After a week of stocks seeming to look for a direction, while still bumping up against all-time highs, the major stock indexes were all indicated handily lower on Thursday morning. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altice USA, CVS Health, Exxon, Lowe’s, T-Mobile, Sprint, Under Armour and More

Stocks closed marginally higher on Monday and were looking for direction on Tuesday. The bull market may be nine years old and stocks may be right at all-time highs, but ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva, Zions and More

Stocks were looking for direction on Monday. Despite the Dow having crossed 22,000 for the first time, we are now more than a week with days of gains, and this ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, Amazon, AngloGold Ashanti, Bank of America, GE, Disney, Xilinx and More

Stocks were indicated to open sharply higher on Monday after the French election outcome favored Macron and therefore no threat to the EU existence. Even though this bull market is ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Carnival, Facebook, Freeport-McMoRan, Motorola Solutions, Procter & Gamble and Many More

24/7 Wall St. reviews dozens of analyst research reports each day of the week. The goal is to find new investing and trading ideas for our readers. Some analyst reports ...
Read Full Story »